Journal details
MOLECULAR DIAGNOSIS & THERAPY
ADIS INT LTD · ISSN 1177-1062 · eISSN 1179-2000
SCIEScopusMEDLINEPubMedPMC
Overview
MOLECULAR DIAGNOSIS & THERAPY is a Genetics & Heredity · Pharmacology & Pharmacy journal published by ADIS INT LTD (New Zealand). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 30 articles · 2025: 62 articles · 2024: 72 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR DIAGNOSIS & THERAPY?
The impact factor recorded for MOLECULAR DIAGNOSIS & THERAPY is 5.8 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR DIAGNOSIS & THERAPY?
MOLECULAR DIAGNOSIS & THERAPY is listed in CAS Zone 3.
Which databases index MOLECULAR DIAGNOSIS & THERAPY?
MOLECULAR DIAGNOSIS & THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.